Annexon (ANNX) Current Assets (2019 - 2026)
Annexon's (ANNX) quarterly Current Assets came in at $228.3 million in Q1 2026, down 14.88% year-on-year from $268.2 million in Q1 2025, and down 5.75% quarter-over-quarter from $242.2 million in Q4 2025.
Annexon (ANNX) Current Assets (2019 - 2026) Analysis & Trends
Annexon's Current Assets history runs 8 years deep, the most recent figure standing at $228.3 million for Q1 2026.
- On a quarterly basis, Current Assets fell 14.88% year-over-year to $228.3 million in Q1 2026; TTM through Mar 2026 was $228.3 million, a 14.88% decrease from a year earlier, with the FY2025 full-year figure at $242.2 million, down 23.47% from the prior year.
- Current Assets retreated to $228.3 million in Q1 2026 per ANNX's latest filing, from $242.2 million in the prior quarter.
- Across five years, Current Assets topped out at $374.0 million in Q2 2024 and bottomed at $169.2 million in Q3 2023.
- The 5-year median for Current Assets is $242.2 million (2025), against an average of $249.8 million.
- Across the five-year window, Current Assets soared 103.52% in 2024 and plunged 43.99% in 2025, its largest moves.
- Year by year, Current Assets stood at $248.1 million in 2022, then grew by 6.35% to $263.9 million in 2023, then rose by 19.94% to $316.5 million in 2024, then retreated by 23.47% to $242.2 million in 2025, then decreased by 5.75% to $228.3 million in 2026.
- Per Business Quant, the three latest ANNX Current Assets figures stand at $228.3 million (Q1 2026), $242.2 million (Q4 2025), and $192.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | 228.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 228.27 Mn |
| Dec 31, 2025 | 242.19 Mn |
| Sep 30, 2025 | 192.82 Mn |
| Jun 30, 2025 | 230.62 Mn |
| Mar 31, 2025 | 268.16 Mn |
| Dec 31, 2024 | 316.46 Mn |
| Sep 30, 2024 | 344.29 Mn |
| Jun 30, 2024 | 373.97 Mn |
| Mar 31, 2024 | 270.74 Mn |
| Dec 31, 2023 | 263.86 Mn |
| Sep 30, 2023 | 169.17 Mn |
| Jun 30, 2023 | 197.56 Mn |
| Mar 31, 2023 | 232.54 Mn |
| Dec 31, 2022 | 248.10 Mn |
| Sep 30, 2022 | 274.78 Mn |
| Jun 30, 2022 | 181.37 Mn |
| Mar 31, 2022 | 211.25 Mn |
| Dec 31, 2021 | 247.69 Mn |
| Sep 30, 2021 | 275.50 Mn |
| Jun 30, 2021 | 304.39 Mn |